Osborne Clarke has a market leading venture and growth capital practice across Europe, renowned for its work in the technology, financial services, renewable energy and life sciences sectors. We act for clients on fund establishment and on investments across the corporate lifecycle and are able to support growth no matter what is needed.

  • For companies and their management teams: We advise on large venture and growth rounds around the globe, typically raising between £10 to £100 million. We handle over 250 investment rounds per year. We also help companies to borrow venture debt facilities, convertible loans and other forms of alternative finance. In addition, we provide incentives, employment, share options, regulatory and IP advice, all specifically focused on venture-backed growth companies in their relevant sector, looking to transform existing markets with their technology.
  • Specifically for start-ups: We also advise on much earlier / smaller seed rounds, usually handling over 100 investments in the sub £5 million range per year (typically £250k to £5m). We will always look at each client as a unique opportunity to help with tailored sector focused support. We offer a range of pricing approaches and to build lasting relationships. We also work with many of the leading research institutions, including Imperial College, King’s College London, UCL, Oxford and Cambridge. We try to operate like your in-house lawyers: always available for you, but without the cost of hiring internal expertise.
  • For investors: We advise a growing number of top tier international funds and corporate investors on international venture and growth capital investments. These investors turn to us for our market knowledge and hands on experience. We also have a fantastic venture funds formation practice to support our institutional client base, and advise both high profile and emerging GPs on their fund formations with a particular focus on the venture space (we are typically working on 5-10 fund formations at any time), providing legal, regulatory and tax support as required.
  • Exits: We are there at all of the key moments, and actively look to help companies (and their investors) get the best terms possible at exit – be that a trade sale or IPO. We have advised numerous VC-backed companies on trade sales to serial technology acquirers such as Cisco, Google, Apple, Facebook and Microsoft.

Find out more >

Experience

N26

Osborne Clarke advised on various funding rounds with a total volume of above $800m, read more.

NewVoiceMedia

We advised on the $350m exit to Vonage Inc, having acted for NVM on its previous equity financings, read more.

MADE.COM

Advised MADE.COM on £40M equity funding round, read more.

Breath Therapeutics

Advised on the sale of Breath Therapeutics to Zambon, read more.

Highland Europe

We advised Highland Europe on three recent series B growth investments: EUR 25m in Camunda; £20m in Farewill and EUR 22m in Modulr.

Business Growth Fund

We advised BGF on its £6m investment in driverless car software developer Oxbotica (as part of a $47m round), read more.

Endeavour Vision

We advised the lead investor on the $30m series D investment in Lumeon – a leader in care pathway orchestration, read more.

Goldman Sachs

Advised Goldman Sachs on $22m Series A funding for DiffBlue and on the Series A funding investment in AI-specialist Eigen Technologies.

Koa Health

We advised the company on a EUR 30m series A round led by Wellington Partners and Ancora, read more.

Secure Code Warrior

Advised Secure Code Warrior on the closure of its $47.6M Series B round led by Goldman Sachs. Read more >

LAVA Therapeutics

We advised on the $83 million Series C financing led by Novo Ventures and Sanofi Ventures, read more.

Community Fibre

We advised the Company, the London Gigafast broadband provider, on a £50m funding round from RPMI and Amber Infrastructure, read more.

Notion

Advised on fund IV formation.

firstminute capital

Advising firstminute on its establishment and launch of its two venture funds, most recently firstminute capital II LP (target $125m)

Passion Capital

Advising Passion Capital on the launch of its third venture fund, Passion Capital III LP (£[60]m).

PROfounders

Advising PROfounders on its establishment and launch of its second fund (£[60m])

MMC

Advising on the MMC Scale-up Fund and MMC Greater London Fund.

Insights